The primetime special from Oprah Winfrey examined the rise of GLP-1 drugs like Ozempic and Mounjaro as well as the need to do away with obesity shaming.
Novo Nordisk’s Wegovy campaign focuses on how HCPs treat obesity
Telehealth firms have sought to cash in on the popularity of GLP-1 drugs for weight loss, but a hefty new entrant could prove a bigger windfall for Novo and Lilly in obesity.
‘Outdated notions’ holding back use of effective obesity drugs: report
As Novo Nordisk and other firms gear up to promote a new class of obesity drugs, success depends on marketers helping separate medical fact from TikTok fiction.